Open access peer-reviewed Edited Volume

Thyroid Cancer


Incidence Oncogenes Tumor Suppressor Genes Papillary Thyroid Carcinoma Follicular Thyroid Carcinoma Prognostic Factors Lymph Node Metastases Extra-Thyroidal Invasion Thyroidectomy Radioiodine Medullary Thyroid Carcinom Anaplastic Thyroid Carcinoma

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

Thyroid cancer is the most common endocrine cancer. The incidence of thyroid cancer is increasing worldwide. New developments have emerged in the research efforts to define the molecular biology and pathophysiology of thyroid cancer. Various oncogenes which are implicated in thyroid cancer pathogenesis have been described and their significance in thyroid cancer prognosis has been investigated. The prognosis of specific thyroid cancer subtypes has been investigated. The therapeutic and prognostic significance of lymph node metastatic disease has been defined. Thyroid cancer treatment is now in the focus of research interest. The use of surgery and its extent in the treatment of thyroid cancer is discussed. The role of radioiodine in the treatment of thyroid cancer is also intensively discussed. Major advances in the drug treatment of advanced thyroid cancer have emerged. In particular, the use of multiple kinase inhibitors has revolutionized the management of advanced thyroid cancer. The treatment of medullary thyroid carcinoma is also a field which has seen major advances. Various efforts have been made to delineate the biology and pathophysiology of anaplastic thyroid carcinoma, which is a deadly cancer, and some have shed some light into its pathogenesis.

Publishing process

Book initiated and editor appointed

Date completed: December 6th 2019

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Approved chapters written in full and submitted

Deadline for full chapters: February 25th 2020

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: May 15th 2020

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: July 14th 2020

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Ifigenia Kostoglou-Athanassiou

Asclepeion Hospital

Dr. Ifigenia Kostoglou-Athanassiou is a Consultant of Asclepeion Hospital. Her research interests focus on Endocrinology, Diabetes mellitus and Oncology. She has done extensive research in the field of neuroendocrinology and melatonin. She has also done extenive research in the field of vitamin D. She is a Professor-Advisor at the Hellenic Open University.

View profile

Book chapters authored 0

Books edited 0

Introducing your Author Service Manager

Mrs. Mia Vulovic

Ask a question

Book will be abstracted and indexed in